Anticancer Potential of Cinnamon Bark Extract (Cinnamomum burmanii) with Cisplatin Combination against P-glycoprotein and Apoptotic Influx Biomarkers
Keywords:Cinnamon bark extract, Cisplatin, p-Glycoprotein, CTR1
Objective: To prove the effect of the combination of cinnamon bark extract with cisplatin in reducing efflux and increasing influx in SKOV3 ovarian cancer cell cultures by measuring the expression of p-glycoprotein, CTR1 and the annexim V.
Methods: This research is an experimental study using SKOV3 ovarian cancer cells stored in the SCTE IMERI FKUI Laboratory, carried out in the Stem Cells and Tissues Engineering Research Cluster laboratory. The cells were then harvested by adding trypsin-EDTA to the culture as much as 1 mL, and rotated at 2000 rpm for 5 minutes. Then the cells were added with antibodies and dissolved with a stain buffer solution and read on a flow cytometry device. We used ethyl acetate extract from cinnamon bark against the SKOV3 cell line . IC50 of Cinnamon bark extract we got from MTS test. We tested the levels of IC50, 3/4 IC50, 1/2 IC50, and 1/4 IC50 of cinnamon bark extract with a combination of IC50, 3/4 IC50 , 1/2 IC50, and 1/4 IC50 cisplatin against the viability of the SKOV3 cell line with single cisplatin IC50 comparator. We also examined the levels of annexin V as a marker of apoptosis in the SKOV3 cell line to see if the cell cycle arrest induced by cinnamon bark extract could cause apoptosis of the SKOV3 cell line. We assessed the sample distribution using the Shapiro-Wilk test because of the sample size . To assess the comparison of parameters (differences in p Glycoprotein and CTR-1 expression between treatment groups in normally distributed data, the test was used analysis of variance (ANOVA). ANOVA is a comparative test to analyze the difference in the mean (mean) of data from two or more variables in the same population. The Bonferroni test was used to analyze the same or different samples (equal and unequal) in each treatment.
Results: From this study, it was found that the combination of IC 50 cinnamon bark extract and IC 50 cisplatin was able to lower p-glycoprotein levels higher with a lower mean value than the other treatment groups with p<0.001. In the test group, the lowest p-glycoprotein expression was found in the combination 1 test group, namely the 1 x IC50 combination. The value of p-glycoprotein expression in the combination group 1 was 1.20%. As for CTR 1, the combination of IC 50 cinnamon bark and IC 50 cisplatin, had the highest CTR1 levels among the three other treatment groups, with p > 0.001. In the test group, the highest CTR1 expression was found in the combination 1 test group, namely the 1 x IC50 combination. The value of CTR1 expression in the combination group 1 was 12%.
Conclusion: The combination of cinnamon bark extract with cisplatin was shown to reduce efflux by decreasing p-glycoprotein expression and increasing influx by increasing CTR1 expression in SKOV3 ovarian cancer cell cultures.
Plum Analytics Artifact Widget Block
Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4)284-96. https://doi.org/10.3322/caac.21456 PMid:29809280 DOI: https://doi.org/10.3322/caac.21456
Jayson GC, Kohn EC, Kitchener HC, Ledermann JA, Anggraini DT, Prihanta W, et al. Ovarian cancer. The use of cinnamon stem extract (Cinnamomum burmannii) on the quality of nata de coco drinks. Lancet. 2014;384(9951):1376-88. https://doi.org/10.1016/S0140-6736(13)62146-7 PMid:24767708 DOI: https://doi.org/10.1016/S0140-6736(13)62146-7
Siegel RL, Miller KD, Jemal A. Cancer statistics 2016. CA Cancer J Clin. 2016;66(1):7-30. https://doi.org/10.3322/caac.21332 PMid:26742998 DOI: https://doi.org/10.3322/caac.21332
La Vecchia C. Ovarian cancer: Epidemiology and risk factors. Eur J Cancer Prev. 2017;26(1)55-62. https://doi.org/10.1097/CEJ.0000000000000217c PMid:26731563 DOI: https://doi.org/10.1097/CEJ.0000000000000217
Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin. 2019;69(64):280-304. https://doi.org/10.3322/caac.21559 PMid:31099893 DOI: https://doi.org/10.3322/caac.21559
Dasari S, Tchounwou PB. Cisplatin in cancer therapy: Molecular mechanism of action. Eur J Pharmacol. 2014;740:364-78. https://doi.org/10.1016/j.ejphar.2014.07.025 PMid:25058905 DOI: https://doi.org/10.1016/j.ejphar.2014.07.025
Anggraini DT, Prihanta W, Purwanti E. Penggunaan Ekstrak Batang Kayu Manis (Cinnamomum burmannii) Terhadap Kualitas Minuman Nata de Coco; 2015.
Larasati YA, Putri DD, Utomo RY, Hermawan A, Meiyanto E. Combination of cisplatin and cinnamon essential oil inhibits hela cells proliferation through cell cycle arrest. J App Pharm Sci. 2014;4(12):14-9. https://doi.org/10.7324/JAPS.2014.41203 DOI: https://doi.org/10.7324/JAPS.2014.41203
Yang XQ, Zheng H, Ye Q, Li RY, Chen Y. Essential oil of Cinnamon exerts anti-cancer activity against head and neck squamous cell carcinoma via attenuating epidermal growth factor receptor tyrosine kinase. J BUON. 2015;20(6):1518-25. PMid:26854449
Dutta A, Chakraborty A. Cinnamon in anticancer armamentarium: A molecular approach. J Toxicol. 2018;1-8. https://doi.org/10.1155/2018/8978731 DOI: https://doi.org/10.1155/2018/8978731
Gerina-Berzina A, Hasnere S, Kolesovs A, Umbrashko S, Muceniece R, Nakurte I. Determination of cisplatin in human blood plasma and urine using liquid chromatography-mass spectrometry for oncological patients with a variety of fatty tissue mass for prediction of toxicity. Exp Oncol. 2017;39(2):124-30. https://doi.org/10.31768/2312-8852.2017.39(2):124-130 PMid:29483491 DOI: https://doi.org/10.31768/2312-8852.2017.39(2):124-130
Miow QH, Tan TZ, Ye J, Lau JA, Yokomizo T, Thiery JP, et al. Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer. Oncogene. 2015;34(15):1899-907. https://doi.org/10.1038/onc.2014.136 PMid:24858042 DOI: https://doi.org/10.1038/onc.2014.136
Mubarak Z, Chismirina S, Qamari CA. Antibacterial activity of cinnamon extract (Cinnamomum burmannii) against the growth of Enterococcus faecalis Mubarak. Cakradonya Dent J. 2016; 8(1):1-10. Available from: http://jurnal.unsyiah.ac.id/CDJ/article/view/10456/8234 [Last accessed on 2021 Sep 11].
Satria D, Furqan M, Rosidah HS. Combinational effects of ethyl acetate extract of picria fel-terrae lour, and doxorubicin on T47D breast cancer cells. Int J Pharm Pharm Sci. 2015;7(7):73-6.
Teng YN, Huang BH, Huang SY, Wu IT, Wu TS, Lee TE, et al. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites. Biomed Pharmacist. 2021;144:112379. https://doi.org/10.1016/j.biopha.2021.112379 PMid:34794239 DOI: https://doi.org/10.1016/j.biopha.2021.112379
Ballard JW, Towarnicki SG. Mitochondria, the gut microbiome and ROS. Cell Signal. 2020;75:109737. https://doi.org/10.1016/j.cellsig.2020.109737 PMid:32810578 DOI: https://doi.org/10.1016/j.cellsig.2020.109737
Tapia G, Diaz-Padill I. Molecular mechanisms of platinum resistance in ovarian cancer. In: Diaz-Padilla I, editor. Ovarian Cancer. A Clinical and Translational Update. London: InTech; 2012. DOI: https://doi.org/10.5772/55562
Banoth B, Cassel SL. Mitochondria in innate immune signaling. Transl Res J Lab Clin Med. 2018;202:52-68. https://doi.org/10.1016/j.trsl.2018.07.014 PMid:30165038 DOI: https://doi.org/10.1016/j.trsl.2018.07.014
Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2013;14(8):518-28. https://doi.org/10.1038/nrm3629 PMid:23877564 DOI: https://doi.org/10.1038/nrm3629
Bompiani KM, Tsai C, Azhatz FP, Liebig JK, Howell, SB. Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of Cisplatin sensitivity. Metallomics. 2016;8(9):951-62. https://doi.org/10.1039/c6mt00076b PMid:27157188 DOI: https://doi.org/10.1039/C6MT00076B
Brasseur K, Gévry N, Asselin E. Chemoresistance and targeted therapies in ovarian and endometrial cancers. Oncotarget. 2017;8(3):4008-42. https://doi.org/10.18632/oncotarget.14021 PMid:28008141 DOI: https://doi.org/10.18632/oncotarget.14021
Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148-60. https://doi.org/10.1038/s41583-019-0132-6 PMid:30737462 DOI: https://doi.org/10.1038/s41583-019-0132-6
Cardoso-Ugarte GA, López-Malo A, Sosa-Morales ME. Cinnamon (Cinnamomum zeylanicum) essential oils. In: Preedy VR, editor. Essential Oils in Food Preservation, Flavor and Safety. Ch. 38. San Diego: Academic Press; 2015. p. 339-47. https://doi.org/10.1016/B978-0-12-416641-7.00038-9 DOI: https://doi.org/10.1016/B978-0-12-416641-7.00038-9
Cai J, Yang J, Jones D. Mitochondrial control of apoptosis: The role of cytochrome c. Biochim Biophys Acta. 1998;1366(1-2):139-49. https://doi.org/10.1016/s0005-2728(98)00109-1 PMid:9714780 DOI: https://doi.org/10.1016/S0005-2728(98)00109-1
Chan HK, Ismail S. Side effects of chemotherapy among cancer patients in a Malaysian general hospital: Experiences, perceptions and informational needs from clinical pharmacists. Asian Pac J Cancer Prev. 2014;15(13):5305-9. https://doi.org/10.7314/APJCP.2014.15.13.5305 PMid:25040993 DOI: https://doi.org/10.7314/APJCP.2014.15.13.5305
Chen BJ, Fu CS, Li GH, Wang XN, Lou HX, Ren DM, et al. Cinnamaldehyde analogues as potential therapeutic agents. Mini Rev Med Chem. 2017;17(1):33-43. https://doi.org/10.2174/1389557516666160121120744 PMid:26791737 DOI: https://doi.org/10.2174/1389557516666160121120744
Damia G, Broggini M. Platinum resistance in ovarian cancer: Role of DNA repair. Cancers (Basel). 2019;11(1):119. https://doi.org/10.3390/cancers11010119 DOI: https://doi.org/10.3390/cancers11010119
How to Cite
Copyright (c) 2022 Sarah Dina, M. Fidel Ganis Siregar, Nelva K. Jusuf, Poppy Anjelisa Hasibuan, Andrijono Andrijono, Adang Bachtiar, Sarma N. Lumbanraja, Iqbal Pahlevi Nasution (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.